Product Comparison


  Bayer Healthcare Pharmaceuticals Inc 50419042301 Pfizer Pharmaceuticals (Brand) 00009737611 Auromedics Pharmaceuticals 55150033001 Mylan Pharmaceuticals 00378334053 Pfizer Pharmaceuticals (Brand) 00009470913
McKesson # 1126374 811706 1233170 885048 721146
Description Mirena® Levonorgestrel 52 mg Intrauterine Device Carton 1 Device Depo-Provera® CI Medroxyprogesterone Acetate 150 mg / mL Injection Prefilled Syringe 1 mL Medroxyprogesterone Acetate 150 mg / mL Injection Prefilled Syringe 1 mL Xulane™ Norelgestromin / Ethinyl Estradiol 150 mcg - 35 mcg / 24 Hour Patch Pouch 3 Patches depo-subQ provera 104™ Medroxyprogesterone Acetate 104 mg / 0.65 mL Injection Prefilled Syringe 0.65 mL
Manufacturer # 5041904230100009737611551500330010037833405300009470913
Brand Mirena®Depo-Provera® CI Xulane™depo-subQ provera 104™
Manufacturer Bayer Healthcare Pharmaceuticals IncPfizer Pharmaceuticals (Brand)Auromedics PharmaceuticalsMylan PharmaceuticalsPfizer Pharmaceuticals (Brand)
Invoice MIRENA, IUD SYSTEM 52MG D/SDEPO-PROVERA SAF, SYR 150MG/ML1ML 9PFIZMEDROXYPROGESTERONE ACETATE, PFS 150MG/ML 1MLXULANE NORELGES, PATCH 150-35MG/24HR (3/CT)DEPO-SUBQ PROVERA, SYR 104MG/0.65ML 0.65ML 9PRDGY
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 1734904266275720547241631753
Container Type CartonPrefilled SyringePrefilled SyringePouchPrefilled Syringe
Country of Origin FinlandUnknownUnknownUnknownUnknown
Dosage Form Intrauterine DeviceInjectionInjectionPatchInjection
Generic Drug Code 1163911254112541552424471
Generic Drug Name LevonorgestrelMedroxyprogesterone AcetateMedroxyprogesterone AcetateNorelgestromin / Ethinyl EstradiolMedroxyprogesterone Acetate
NDC Number 5041904230100009737611551500330010037833405300009470913
Product Dating McKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 days
Quantity 1 Device3 Patches
Strength 52 mg150 mg / mL150 mg / mL150 mcg - 35 mcg / 24 Hour104 mg / 0.65 mL
Type IntramuscularIntramuscularTransdermalSubcutaneous
UNSPSC Code 4214310351351612513515095135241451351612
Volume 1 mL1 mL0.65 mL
Application Contraceptive AgentContraceptive AgentContraceptive AgentContraceptive AgentContraceptive Agent
Features and Benefits
  • Depo-Provera CI is a progestin indicated only for the prevention of pregnancy
  • The recommended dose is 150 mg of Depo-Provera CI every 3 months (13 weeks) administered by deep, intramuscular (IM) injection in the gluteal or deltoid muscle
  • Prefilled syringes packaged with 22-gauge x 1-1/2 inch Terumo® SurGuard™ needles
  • Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP]
  • depo-subQ provera 104 must be given by subcutaneous injection into the anterior thigh or abdomen, once every 3 months (12 to 14 weeks)
  • depo-subQ provera 104 is not formulated for intramuscular injection
  • The pre-filled syringe of depo-subQ provera 104 must be vigorously shaken just before use to create a uniform suspension
  • Supplied as a pre-filled syringe, packaged with a 26-gauge x 3/8 inch Terumo® Surguard™ needle
  • Store at controlled room temperature 20º to 25º C (68º to 77ºF)